லோன் ஆஂக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from லோன் ஆஂக். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In லோன் ஆஂக் Today - Breaking & Trending Today

Oncimmune inks disease panel pacts with Roche, Cedars-Sinai Medical Center | 6 April 2021


6 April 2021 | 07:44am
StockMarketWire.com - Immunodiagnostics group Oncimmune said it had signed two separate agreements with Roche Pharmaceuticals and Cedars-Sinai Medical Center for use of the company s newly developed infectious disease panel.
Oncimmune had in October announced the award of UK government funding for the development and validation of an infectious disease NavigAID panel.
Utilising the data from this and other work, the company s current SeroTag research panel has been tailored to predict Covid-19 disease severity and therapeutic response to the virus and the effectiveness of vaccines and other repurposed therapeutics as treatment against the disease, the company said. ....

United Kingdom , Sinai Medical Center , Roche Pharmaceuticals , Cedars Sinai Medical Center , Oncimmune Holdings Plc , Lon Onc , Onc L , ஒன்றுபட்டது கிஂக்டம் , சினை மருத்துவ மையம் , ரோச் மருந்துகள் , சிடார் சினை மருத்துவ மையம் , லோன் ஆஂக் , ஆஂக் ல் ,

Oncimmune losses narrow as sales rise | 15 February 2021


15 February 2021 | 07:54am
StockMarketWire.com - Immunodiagnostics group Oncimmune posted a narrower first-half loss on the back of higher revenue and lower R&D spending.
Pre-tax losses for the six months through November amounted to £2.8 million, compared to losses of £5.5 million year-on-year.
Revenue rose to £1.8 million, up from £0.3 million.
Oncimmune said it saw a marked increase in commercial activity as large pharmaceutical and biotech companies utilised its biomarker discovery platform technology tools.
Seven such contracts had been signed in the period, including with Roche Pharmaceuticals and Genentech, with work on those recently completed or very advanced.
In addition, first commercial contracts had been signed to supply a lung cancer diagnostic blood test to the National Health Service, with patient samples already analysed. ....

Adamm Hill , Roche Pharmaceuticals , National Health Service , Oncimmune Holdings Plc , Lon Onc , Onc L , ரோச் மருந்துகள் , தேசிய ஆரோக்கியம் சேவை , லோன் ஆஂக் , ஆஂக் ல் ,